CAMP4 Therapeutics Corporation (CAMP) vs Nautilus Biotechnolgy, Inc. (NAUT)
A side-by-side comparison of CAMP4 Therapeutics Corporation and Nautilus Biotechnolgy, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CAMP
CAMP4 Therapeutics Corporation
$3.96HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
NAUT
Nautilus Biotechnolgy, Inc.
$1.77HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — CAMP vs NAUT
growth of $100 · dividends reinvested · last 2yCAMP -62.6% (-38.8%/yr)NAUT -31.0% (-16.9%/yr)NAUT compounded faster over this window
CAMP NAUT
CAMP vs NAUT: by the numbers
- •CAMP is the larger company ($249M vs $225M market cap).
- •Both run net losses; CAMP's is the smaller (-2543.74% vs -29747.89% net margin).
Metrics side by side
Valuation
| Metric | CAMP | NAUT |
|---|---|---|
| P/S ratio | 58.94 | 1185.48 |
| P/B ratio | N/A | 1.72 |
Profitability
| Metric | CAMP | NAUT |
|---|---|---|
| Gross margin | 53.14% | 0.00% |
| Operating margin | -1488.31% | 0.00% |
| Net margin | -2543.74% | -29747.89% |
| ROE | N/A | -43.11% |
| ROIC | -69.76% | -40.52% |
Growth (annualized)
| Metric | CAMP | NAUT |
|---|---|---|
| Revenue CAGR (5Y) | -57.68% | N/A |
| Total return CAGR (5Y) | N/A | -20.56% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.